Discussion
Children with spinal muscular atrophy (SMA) already living with symptoms experienced gains in motor abilities after receiving the gene therapy Zolgensma (onasemnogene abeparvovec-xioi), a small Brazilian study found. The real-world report tracked the outcomes of seven youngsters in the South American nation who were treated with Zolgensma only…